Skip to main content
Year archive

Cellid Co., Ltd. — 2020 filings

All 35 regulatory filings released by Cellid Co., Ltd. (299660) in 2020, sourced directly from the official regulator.

35 Filings
2020 Period
2020 filings (35)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-15 Korean
투자판단관련주요경영사항(코로나바이러스감염증-19 예방백신 임상 1/2a상 시험 계획 승인)
Legal Proceedings Report
2020-12-04 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2020-11-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-11-06 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2020-11-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-10-12 Korean
투자판단관련주요경영사항(코로나바이러스감염증-19(COVID-19) 예방백신(AdCLD-CoV19) 임상 제1/2a상 시험 계획(IND) 승인 신청)
Regulatory Filings
2020-10-07 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-09-16 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2020-08-20 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2020-08-18 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-13 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-08-12 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-08-12 Korean
기타경영사항(자율공시)(국책과제 선정(아데노바이러스 벡터에 기반한 1세대 및 2세대 코비드-19 예방백신 개발)
Regulatory Filings
2020-07-31 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-06-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2020-06-17 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-04-01 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-03-25 Korean
투자판단관련주요경영사항(항암면역치료백신 BVAC-P의 임상 1상 시험 계획 승인)
Regulatory Filings
2020-03-24 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-10 Korean
주주총회소집결의
AGM Information
2020-02-25 Korean
주주총회집중일개최사유신고
AGM Information
2020-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-02-25 Korean
합병등종료보고서(자산양수도)
M&A Activity
2020-02-21 Korean
[첨부추가]주요사항보고서(유형자산양수결정)
Capital/Financing Update
2020-02-03 Korean
합병등종료보고서(자산양수도)
M&A Activity
2020-01-31 Korean
투자판단관련주요경영사항(항암면역치료백신 BVAC-B의 임상 1상 시험 종료)
Legal Proceedings Report
2020-01-21 Korean